全球克隆與誘變市場規模、佔有率、趨勢及成長分析報告（2026-2034）

克隆和誘變技術市場預計將從 2025 年的 51.9 億美元成長到 2034 年的 252.1 億美元，2026 年至 2034 年的複合年成長率為 19.21%。

受分子生物學、遺傳學和生物技術領域研究活動的日益活躍的推動，全球克隆和誘變市場正經歷穩步成長。學術機構、製藥公司和合約研究組織（CRO）正在增加基因編輯和重組DNA技術的投資。基因組學研究和個人化醫療的進步進一步刺激了全球實驗室對克隆試劑盒、酵素和誘變工具的需求。

關鍵成長要素包括基於CRISPR的基因編輯技術的進步、生命科學研究經費的增加以及生物製藥的快速發展。研究人員正在利用克隆和誘變技術來闡明基因功能、建立疾病模型並開發標靶治療。遺傳性疾病和癌症的日益普遍，加速了對能夠支持藥物發現和治療方法開發的創新分子工具的需求。

展望未來，市場有望進一步受益於實驗室工作流程的自動化和高通量篩檢技術的進步。新興經濟體研究基礎設施的擴展將創造新的成長機會。合成生物學和精準醫學領域的持續創新將進一步推動需求，克隆和誘變技術有望成為未來生物醫學研究和治療突破的關鍵要素。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球克隆與誘變市場：依產品分類

• 市場分析、洞察與預測
• 克隆試劑盒
• 誘變試劑盒

第5章 全球克隆與誘變市場：依技術分類

• 市場分析、洞察與預測
• TOPO PCR克隆
• 位點特異性突變引入

第6章 全球克隆與誘變市場：依最終用途分類

• 市場分析、洞察與預測
• 生物製藥和製藥公司
• 合約研究組織 (CRO) 和合約行銷組織 (CMO)

第7章 全球克隆與誘變市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Agilent Technologies Inc
  • Thermo Fisher Scientific Inc
  • New England Biolabs
  • Takara Bio Inc
  • Merck KGaA
  • Promega Corporation
  • Bio-Rad Laboratories Inc
  • Danaher
  • Jena Bioscience GmbH
  • Assay Genie
  • TransGen Biotech Co. Ltd

The Cloning And Mutagenesis Market size is expected to reach USD 25.21 Billion in 2034 from USD 5.19 Billion (2025) growing at a CAGR of 19.21% during 2026-2034.

The Global Cloning and Mutagenesis Market is witnessing steady growth due to rising research activities in molecular biology, genetics, and biotechnology. Academic institutions, pharmaceutical companies, and contract research organizations are increasingly investing in gene editing and recombinant DNA technologies. The expansion of genomics research and personalized medicine has further strengthened demand for cloning kits, enzymes, and mutagenesis tools across research laboratories worldwide.

Key growth drivers include advancements in CRISPR-based gene editing, increased funding for life science research, and the rapid development of biopharmaceuticals. Researchers are using cloning and mutagenesis techniques to understand gene function, create disease models, and develop targeted therapies. The growing prevalence of genetic disorders and cancer has accelerated the need for innovative molecular tools that can support drug discovery and therapeutic development.

Looking ahead, the market is expected to benefit from automation in laboratory workflows and improved high-throughput screening technologies. Emerging economies are expanding their research infrastructure, which will create new growth opportunities. Continuous innovation in synthetic biology and precision medicine is likely to further drive demand, positioning cloning and mutagenesis technologies as essential components of future biomedical research and therapeutic breakthroughs.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Cloning Kits
• Mutagenesis Kits

By Technology

• TOPO PCR Cloning
• Site-directed Mutagenesis

By End Use

• Biopharmaceuticals and Pharmaceutical Companies
• CROs and CMOs

COMPANIES PROFILED

• Agilent Technologies Inc, Thermo Fisher Scientific Inc, New England Biolabs, Takara Bio Inc, Merck KGaA, Promega Corporation, BioRad Laboratories Inc, Danaher, Jena Bioscience GmbH, Assay Genie, TransGen Biotech Co Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CLONING AND MUTAGENESIS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Cloning Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Mutagenesis Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CLONING AND MUTAGENESIS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. TOPO PCR Cloning Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Site-directed Mutagenesis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CLONING AND MUTAGENESIS MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Biopharmaceuticals and Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. CROs and CMOs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CLONING AND MUTAGENESIS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Technology
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Technology
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Technology
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Technology
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Technology
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CLONING AND MUTAGENESIS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Agilent Technologies Inc
  • 9.2.2 Thermo Fisher Scientific Inc
  • 9.2.3 New England Biolabs
  • 9.2.4 Takara Bio Inc
  • 9.2.5 Merck KGaA
  • 9.2.6 Promega Corporation
  • 9.2.7 Bio-Rad Laboratories Inc
  • 9.2.8 Danaher
  • 9.2.9 Jena Bioscience GmbH
  • 9.2.10 Assay Genie
  • 9.2.11 TransGen Biotech Co. Ltd